On November 6, 2026, Network Bio announced a research collaboration with Duke University to develop AI models of human disease using biospecimens and clinical data.
The partners plan to select disease-specific groups from Duke’s biobanks, profile tissue and blood samples, and link molecular findings with de-identified clinical records and outcomes under approved research protocols.
Network Bio says the resulting datasets will support research into earlier disease detection, treatment matching, and new drug-target discovery.
Molecular data generated through the work will also be returned to Duke’s biobanks for academic research. The agreement provides for research and commercial uses, including AI development and data licensing, subject to its terms and applicable privacy and security requirements.
These are intended research applications; the announcement does not report that the models have been clinically validated or that they are already improving patient outcomes.
Sources:
Network Bio partners with Duke University on AI disease models
New partnership will expand research opportunities at Duke
$50M Initiative Aims to Build AI-Ready Datasets Across ...
Network Bio Launches with $50 Million Financing and World's Largest Patient Tissue Training Dataset
College and University Breaking News and Press Releases
BioBuzz | Biotech and Life Science News, Jobs, and Events for the BioHealth Capital Region